Risk of depression and anxiety in employees with chronic bronchitis: The modifying effect of cigarette smoking

Psychosomatic Medicine

Volumn 66, Issue 5, 2004, Pages 729-734

  Wagena, Edwin J ^a,c   Kant, Ijmert ^a   Van Amelsvoort, Ludovic G P M ^a   Wouters, Emiel F M ^b   Van Schayck, Constant P ^a   Swaen, Gerard M H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Pulmon Rehab Centre Homerheide   (Netherlands)

Author keywords

Anxiety; Chronic bronchitis; Depression

Indexed keywords

ADULT; ANXIETY; ARTICLE; CHRONIC BRONCHITIS; CIGARETTE SMOKING; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; EMPLOYEE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 4944229404     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000138127.00991.cf     Document Type: Article

References (35)

1. Alexopoulos EC, Burdorf A. Prognostic factors for respiratory sickness absence and return to work among blue collar workers and office personnel. Occup Environ Med 2001;58:246-52.
2. Rutten-van Mölken MPMH, Van Doorslaer EKA, Rutten FFH. Economic appraisal of asthma and COPD care: a literature review 1980-1991. Soc Sci Med 1992;35:161-75.
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
4. Roche N, Huchon GJ. Current issues in the management of chronic obstructive pulmonary disease. Respirology 1997;2:215-29.
5. US Department of Health and Human Services The health consequences of smoking: chronic obstructive lung disease. Rockville, MD: Office on Smoking and Health, Department of Health and Human Services; 1984.
6. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;52:S77-121.
7. BTS guidelines for the management of chronic obstructive pulmonary disease: the COPD Guideline Group of the Standards of Care Committee of the BTS. Thorax 1997;52(suppl 5):S1-28.
8. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995;8:1398-420.
9. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, Scanlon PO, Tashkin DP, Wise RA. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497-505.
10. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992;146:1345-8.
11. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J. Smoking, smoking cessation, and major depression. JAMA 1990;264:1546-9.
12. Covey LS. Tobacco cessation among patients with depression, Primary Care 1999;26:691-706.
13. Franssen PML, Bültmann U, Kant I, van Amelsvoort LGPM. The association between chronic diseases and fatigue in the working population. J Psychosom Res 2003;54:339-44.
14. Cassileth BR, Lusk EJ, Strouse TB, Miller DS, Brown LL, Cross PA, Tenaglia AN. Psychosocial status in chronic illness: a comparative analysis of six diagnostic groups. N Engl J Med 1984;311:506-11.
15. Dudley DL, Glaser EM, Jorgenson BN, Logan DL. Psychosocial concomitants to rehabilitation in chronic obstructive pulmonary disease, part I: psychosocial and psychological considerations. Chest 1980;77:413-20.
16. Peveler R, Carson A, Rodin G. ABC of psychological medicine: depression in medical patients. BMJ 2002;325:149-52.
17. Buist AS. Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes. Eur Respir J 2003;21:30s-5s.
18. Barnes PJ. Mechanisms in COPD: differences from asthma. Chest 2000;117:10-14s.
19. Dierker LC, Avenevoli S, Stolar M, Merikangas KR. Smoking and depression: an examination of mechanisms of comorbidity. Am J Psychiatry 2002;159:947-53.
20. Glassman AH, Stetner F, Walsh BT, Raizman PS, Fleiss JL, Cooper TB, Covey LS. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988;259:2863-6.
21. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA 2000;284:2606-10.
22. Kant IJ, Bültmann U, Schröer CAP, Beurskens AJHM, van Amelsvoort LGPM, Swaen GMH. An epidemiological approach to study fatigue in the working population: the Maastricht Cohort Study. Occup Environ Med 2003;60:i32-9.
23. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343:269-80.
24. Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their committee on the etiology of chronic bronchitis. Lancet 1965;i:775-9.
25. Fletcher C, Pride NB. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax 1984;39:81-5.
26. Spinhoven P, Ormel J, Sloekers PP, Kempen GIJM, Speckens AEM, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997;27:363-70.
27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
28. Bjelland I, Dahl AA, Tangen Haug T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated review. J Psychosom Res 2002;52:69-77.
29. Van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002;57:412-6.
30. Oswald NC, Waller RE, Drinkwater J. Relationship between breathlessness and anxiety in asthma and bronchitis: a comparative study. Br Med J 1970;2:14-7.
31. Wagena EJ, Huibers MJ, van Schayck CP. Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression. Thorax 2001;56:587-8.
32. Dahlén I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002;122:1633-7.
33. McCathie HCF, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J 2002;19:47-53.
34. Dekhuijzen PNR, Beek MML, Folgering HTM, Van Herwaarden CLA. Psychological changes during pulmonary rehabilitation and target-flow inspiratory muscle training in COPD patients with a ventilatory limitation during exercise. Int J Rehabil Res 1990;13:109-17.
35. Van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999;54:688-92.